Clinical Trial Update: Microtransplantation With Decitabine and Cytarabine Improves Patient Outcomes in Myelodysplastic Syndromes [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial reports results for microtransplantation with decitabine and cytarabine in myelodysplastic syndromes, noting improved patient outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Decitabine (Decitabine)

Snippet

Sponsor: The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | Conditions: Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: COMPLETED